Skip to main content
. 2016 Dec 21;8(5):8057–8068. doi: 10.18632/oncotarget.14074

Table 4. Univariate Analysis for Overall Survival.

Variables N Overall survival P
Median±SE 95%CI
Rap1GAP
 high 42 50.00±4.32 41.53-58.46
 low 136 32.00±0.89 30.37-33.62 <0.001
E-cadherin
 high 60 41.00±3.32 34.49-47.50
 low 118 32.00±1.80 28.45-35.54 0.091
MMP2
 high 102 30.00±1.12 27.80-32.19
 low 76 46.00±2.72 40.66-51.33 <0.001
Gender
 male 125 34.00±2.97 28.16-39.83
 female 53 38.00±3.63 30.86-45.13 0.973
Age
 ≤60 94 40.00±3.87 32.40-47.59
 >60 84 32.00±1.13 29.77-34.22 0.223
TNM
 I 21 49.00±3.21 42.69-66.71
 II 34 45.00±5.83 33.57-56.42
 III 83 34.00±2.27 29.53-38.46
 IV 40 29.00±1.57 25.91-32.08 <0.001
Depth of invasion
 T1 16 46.00±8.66 29.01-62.98
 T2 18 52.00±15.91 20.81-83.18
 T3 67 35.00±4.60 25.98-44.01
 T4 77 31.00±1.45 28.14-33.86 0.005
Nodal involvement
 N0 49 55.00±9.79 35.79-74.20
 N1 36 43.00±7.80 27.22-58.78
 N2 35 36.00±3.54 29.04-42.95
 N3 58 29.00±2.53 24.03-33.96 <0.001
Metastasis
 M0 138 40.00±3.91 32.32-47.67
 M1 40 29.00±1.57 25.91-32.08 <0.001
Borrmann type
 I 22 39.00±7.62 24.06-53.93
 II 55 40.00±3.69 32.76-47.23
 III 62 34.00±3.50 27.14-40.85
 IV 39 30.00±1.77 27.51-34.48 0.502
Differentiation
 high 12 40.00±6.06 28.11-51.88
 moderate 57 39.00±6.11 26.97-51.02
 poor 109 32.00±1.74 28.59-35.41 0.107
Tumor diameter
 <3 cm 44 46.00±5.20 35.79-56.20
 3 cm-5 cm 54 34.00±1.83 30.40-37.51
 >5 cm 80 32.00±0.98 30.06-33.93 0.019